Evidence map›Paper›PMID 39883102›Full record

ArticleLung cancer management2025

Moving towards single fraction peripheral lung stereotactic body radiation therapy: patient care during and after the global COVID-19 pandemic.

Salem Alfaifi, Vibhay Pareek, Julian Kim, Shrinivas Rathod, William Hunter, Ahmet Leylek, Naseer Ahmed, Sankar Venkataraman, Niranjan Venugopal, Amitava Chowdhury and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Lung cancer management, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Salem AlfaifiDepartment of Radiation Oncology, University of Manitoba, Winnipeg, MB, Canada.
Vibhay PareekDepartment of Radiation Oncology, University of Manitoba, Winnipeg, MB, Canada.
Julian KimDepartment of Radiation Oncology, University of Manitoba, Winnipeg, MB, Canada.
Shrinivas RathodDepartment of Radiation Oncology, University of Manitoba, Winnipeg, MB, Canada.
William HunterDepartment of Radiation Oncology, University of Manitoba, Winnipeg, MB, Canada.
Ahmet LeylekDepartment of Radiation Oncology, University of Manitoba, Winnipeg, MB, Canada.
Naseer AhmedDepartment of Radiation Oncology, University of Manitoba, Winnipeg, MB, Canada.
Sankar VenkataramanDepartment of Medical Physics, University of Manitoba, Winnipeg, MB, Canada.
Niranjan VenugopalDepartment of Medical Physics, University of Manitoba, Winnipeg, MB, Canada.
Amitava ChowdhuryDepartment of Radiation Oncology, University of Manitoba, Winnipeg, MB, Canada.
Arbind DubeyDepartment of Radiation Oncology, University of Manitoba, Winnipeg, MB, Canada.
Saranya KakumanuDepartment of Radiation Oncology, University of Manitoba, Winnipeg, MB, Canada.
Bashir BashirDepartment of Radiation Oncology, University of Manitoba, Winnipeg, MB, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Lung CancerNon-small-cell lung cancerOligometastasesSBRTSingle Fraction

Identifiers

PMID39883102
PMCPMC12520096

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.